- Home
- BCML vs GOSS Comparison
BCML vs GOSS Comparison
Compare BCML & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- GOSS
- Stock Information
- Founded
- BCML 2004
- GOSS 2015
- Country
- BCML United States
- GOSS United States
- Employees
- BCML N/A
- GOSS N/A
- Industry
- BCML Major Banks
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- GOSS Health Care
- Exchange
- BCML Nasdaq
- GOSS Nasdaq
- Market Cap
- BCML 261.8M
- GOSS 230.8M
- IPO Year
- BCML N/A
- GOSS 2019
- Fundamental
- Price
- BCML $23.48
- GOSS $1.01
- Analyst Decision
- BCML
- GOSS Strong Buy
- Analyst Count
- BCML 0
- GOSS 5
- Target Price
- BCML N/A
- GOSS $9.20
- AVG Volume (30 Days)
- BCML 19.5K
- GOSS 972.9K
- Earning Date
- BCML 10-21-2024
- GOSS 11-07-2024
- Dividend Yield
- BCML 1.67%
- GOSS N/A
- EPS Growth
- BCML N/A
- GOSS N/A
- EPS
- BCML 2.12
- GOSS N/A
- Revenue
- BCML $97,490,000.00
- GOSS $95,842,000.00
- Revenue This Year
- BCML N/A
- GOSS N/A
- Revenue Next Year
- BCML $3.40
- GOSS N/A
- P/E Ratio
- BCML $11.02
- GOSS N/A
- Revenue Growth
- BCML N/A
- GOSS N/A
- 52 Week Low
- BCML $18.54
- GOSS $0.45
- 52 Week High
- BCML $25.04
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- BCML 54.46
- GOSS 54.19
- Support Level
- BCML $23.27
- GOSS $0.98
- Resistance Level
- BCML $23.62
- GOSS $1.09
- Average True Range (ATR)
- BCML 0.37
- GOSS 0.07
- MACD
- BCML -0.06
- GOSS 0.00
- Stochastic Oscillator
- BCML 24.07
- GOSS 43.18
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.